H1N1 vaccine trials in HIV-infected people

BETHESDA, Md., Oct. 12 (UPI) — The first clinical trial of the H1N1 influenza vaccine in human immunodeficiency virus-infected pregnant women has begun, U.S. officials said.

Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, said a similar trial will begin in HIV-infected children and youth next week.

“These studies are important because HIV infection and pregnancy both increase the risk for a poor immune response to the normal 15-microgram dose of seasonal influenza vaccine given to the general population,” Fauci said in a statement. “Moreover, children, young people and pregnant women are at higher risk for more severe illness from the 2009 H1N1 influenza virus than other groups, and HIV-infected individuals in these populations may be particularly vulnerable.”

One trial will enroll 130 HIV-infected pregnant women ages 18-39, who are in their second or third trimester of pregnancy. The other trial will enroll 140 children and youth ages 4-24 infected with HIV at birth.


0 Responses to “H1N1 vaccine trials in HIV-infected people”

  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow Danny on Twitter!!

Prevention Education Stats

  • 5,203 hits

%d bloggers like this: